Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney

Autores
Piotrkowski, Barbara; Fraga, Cesar G.; De Cavanagh, Elena M. V.
Año de publicación
2007
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
The renal and cardiac benefits of renin-angiotensin system (RAS) inhibition in hypertension exceed those attributable to blood pressure reduction, and seem to involve mitochondrial function changes. To investigate whether mitochondrial changes associated with RAS inhibition are related to changes in nitric oxide (NO) metabolism, four groups of male Wistar rats were treated during 2 wk with a RAS inhibitor, enalapril (10 mg·kg-1·day-1; Enal), or a NO synthase (NOS) inhibitor, Nω-nitro-L-arginine methyl ester (L-NAME) (1 mg·kg-1·day-1), or both (Enal+L-NAME), or were untreated (control). Blood pressure and body weight were lower in Enal than in control. Electron transfer through complexes I to III and cytochrome oxidase activity were significantly lower, and uncoupling protein-2 content was significantly higher in kidney mitochondria isolated from Enal than in those from control. All of these changes were prevented by L-NAME cotreatment and were accompanied by a higher production/bioavailability of kidney NO. L-NAME abolished mitochondrial NOS activity but failed to inhibit extra-mitochondrial kidney NOS, underscoring the relevance of mitochondrial NO in those effects of enalapril that were suppressed by L-NAME cotreatment. In Enal, kidney mitochondria H2O2 production rate and MnSOD activity were significantly lower than in control, and these effects were not prevented by L-NAME cotreatment. These findings may clarify the role of NO in the interactions between RAS and mitochondrial metabolism and can help to unravel the mechanisms involved in renal protection by RAS inhibitors. Copyright © 2007 the American Physiological Society.
Fil: Piotrkowski, Barbara. Universidad de Buenos Aires; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Fraga, Cesar G.. Universidad de Buenos Aires; Argentina. University of California at Davis; Estados Unidos
Fil: De Cavanagh, Elena M. V.. Universidad de Buenos Aires; Argentina
Materia
Angiotensin
Membrane Potential
Uncoupling Protein
N-Nitro-L-Arginine Methyl Esther
Reactive Oxygen Species
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/63046

id CONICETDig_85abb7f45332b586dab99fc10ab43d39
oai_identifier_str oai:ri.conicet.gov.ar:11336/63046
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidneyPiotrkowski, BarbaraFraga, Cesar G.De Cavanagh, Elena M. V.AngiotensinMembrane PotentialUncoupling ProteinN-Nitro-L-Arginine Methyl EstherReactive Oxygen Specieshttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1https://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3The renal and cardiac benefits of renin-angiotensin system (RAS) inhibition in hypertension exceed those attributable to blood pressure reduction, and seem to involve mitochondrial function changes. To investigate whether mitochondrial changes associated with RAS inhibition are related to changes in nitric oxide (NO) metabolism, four groups of male Wistar rats were treated during 2 wk with a RAS inhibitor, enalapril (10 mg·kg-1·day-1; Enal), or a NO synthase (NOS) inhibitor, Nω-nitro-L-arginine methyl ester (L-NAME) (1 mg·kg-1·day-1), or both (Enal+L-NAME), or were untreated (control). Blood pressure and body weight were lower in Enal than in control. Electron transfer through complexes I to III and cytochrome oxidase activity were significantly lower, and uncoupling protein-2 content was significantly higher in kidney mitochondria isolated from Enal than in those from control. All of these changes were prevented by L-NAME cotreatment and were accompanied by a higher production/bioavailability of kidney NO. L-NAME abolished mitochondrial NOS activity but failed to inhibit extra-mitochondrial kidney NOS, underscoring the relevance of mitochondrial NO in those effects of enalapril that were suppressed by L-NAME cotreatment. In Enal, kidney mitochondria H2O2 production rate and MnSOD activity were significantly lower than in control, and these effects were not prevented by L-NAME cotreatment. These findings may clarify the role of NO in the interactions between RAS and mitochondrial metabolism and can help to unravel the mechanisms involved in renal protection by RAS inhibitors. Copyright © 2007 the American Physiological Society.Fil: Piotrkowski, Barbara. Universidad de Buenos Aires; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Fraga, Cesar G.. Universidad de Buenos Aires; Argentina. University of California at Davis; Estados UnidosFil: De Cavanagh, Elena M. V.. Universidad de Buenos Aires; ArgentinaAmerican Physiological Society2007-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/63046Piotrkowski, Barbara; Fraga, Cesar G.; De Cavanagh, Elena M. V.; Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney; American Physiological Society; American Journal Of Physiology-regulatory, Integrative And Comparative Physiology; 292; 4; 4-2007; 1494-15010363-6119CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.physiology.org/doi/full/10.1152/ajpregu.00540.2006info:eu-repo/semantics/altIdentifier/doi/10.1152/ajpregu.00540.2006info:eu-repo/semantics/altIdentifier/pmid/17185409info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:34:12Zoai:ri.conicet.gov.ar:11336/63046instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:34:12.319CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney
title Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney
spellingShingle Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney
Piotrkowski, Barbara
Angiotensin
Membrane Potential
Uncoupling Protein
N-Nitro-L-Arginine Methyl Esther
Reactive Oxygen Species
title_short Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney
title_full Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney
title_fullStr Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney
title_full_unstemmed Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney
title_sort Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney
dc.creator.none.fl_str_mv Piotrkowski, Barbara
Fraga, Cesar G.
De Cavanagh, Elena M. V.
author Piotrkowski, Barbara
author_facet Piotrkowski, Barbara
Fraga, Cesar G.
De Cavanagh, Elena M. V.
author_role author
author2 Fraga, Cesar G.
De Cavanagh, Elena M. V.
author2_role author
author
dc.subject.none.fl_str_mv Angiotensin
Membrane Potential
Uncoupling Protein
N-Nitro-L-Arginine Methyl Esther
Reactive Oxygen Species
topic Angiotensin
Membrane Potential
Uncoupling Protein
N-Nitro-L-Arginine Methyl Esther
Reactive Oxygen Species
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv The renal and cardiac benefits of renin-angiotensin system (RAS) inhibition in hypertension exceed those attributable to blood pressure reduction, and seem to involve mitochondrial function changes. To investigate whether mitochondrial changes associated with RAS inhibition are related to changes in nitric oxide (NO) metabolism, four groups of male Wistar rats were treated during 2 wk with a RAS inhibitor, enalapril (10 mg·kg-1·day-1; Enal), or a NO synthase (NOS) inhibitor, Nω-nitro-L-arginine methyl ester (L-NAME) (1 mg·kg-1·day-1), or both (Enal+L-NAME), or were untreated (control). Blood pressure and body weight were lower in Enal than in control. Electron transfer through complexes I to III and cytochrome oxidase activity were significantly lower, and uncoupling protein-2 content was significantly higher in kidney mitochondria isolated from Enal than in those from control. All of these changes were prevented by L-NAME cotreatment and were accompanied by a higher production/bioavailability of kidney NO. L-NAME abolished mitochondrial NOS activity but failed to inhibit extra-mitochondrial kidney NOS, underscoring the relevance of mitochondrial NO in those effects of enalapril that were suppressed by L-NAME cotreatment. In Enal, kidney mitochondria H2O2 production rate and MnSOD activity were significantly lower than in control, and these effects were not prevented by L-NAME cotreatment. These findings may clarify the role of NO in the interactions between RAS and mitochondrial metabolism and can help to unravel the mechanisms involved in renal protection by RAS inhibitors. Copyright © 2007 the American Physiological Society.
Fil: Piotrkowski, Barbara. Universidad de Buenos Aires; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Fraga, Cesar G.. Universidad de Buenos Aires; Argentina. University of California at Davis; Estados Unidos
Fil: De Cavanagh, Elena M. V.. Universidad de Buenos Aires; Argentina
description The renal and cardiac benefits of renin-angiotensin system (RAS) inhibition in hypertension exceed those attributable to blood pressure reduction, and seem to involve mitochondrial function changes. To investigate whether mitochondrial changes associated with RAS inhibition are related to changes in nitric oxide (NO) metabolism, four groups of male Wistar rats were treated during 2 wk with a RAS inhibitor, enalapril (10 mg·kg-1·day-1; Enal), or a NO synthase (NOS) inhibitor, Nω-nitro-L-arginine methyl ester (L-NAME) (1 mg·kg-1·day-1), or both (Enal+L-NAME), or were untreated (control). Blood pressure and body weight were lower in Enal than in control. Electron transfer through complexes I to III and cytochrome oxidase activity were significantly lower, and uncoupling protein-2 content was significantly higher in kidney mitochondria isolated from Enal than in those from control. All of these changes were prevented by L-NAME cotreatment and were accompanied by a higher production/bioavailability of kidney NO. L-NAME abolished mitochondrial NOS activity but failed to inhibit extra-mitochondrial kidney NOS, underscoring the relevance of mitochondrial NO in those effects of enalapril that were suppressed by L-NAME cotreatment. In Enal, kidney mitochondria H2O2 production rate and MnSOD activity were significantly lower than in control, and these effects were not prevented by L-NAME cotreatment. These findings may clarify the role of NO in the interactions between RAS and mitochondrial metabolism and can help to unravel the mechanisms involved in renal protection by RAS inhibitors. Copyright © 2007 the American Physiological Society.
publishDate 2007
dc.date.none.fl_str_mv 2007-04
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/63046
Piotrkowski, Barbara; Fraga, Cesar G.; De Cavanagh, Elena M. V.; Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney; American Physiological Society; American Journal Of Physiology-regulatory, Integrative And Comparative Physiology; 292; 4; 4-2007; 1494-1501
0363-6119
CONICET Digital
CONICET
url http://hdl.handle.net/11336/63046
identifier_str_mv Piotrkowski, Barbara; Fraga, Cesar G.; De Cavanagh, Elena M. V.; Mitochondrial function and nitric oxide metabolism are modified by enalapril in rat kidney; American Physiological Society; American Journal Of Physiology-regulatory, Integrative And Comparative Physiology; 292; 4; 4-2007; 1494-1501
0363-6119
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.physiology.org/doi/full/10.1152/ajpregu.00540.2006
info:eu-repo/semantics/altIdentifier/doi/10.1152/ajpregu.00540.2006
info:eu-repo/semantics/altIdentifier/pmid/17185409
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv American Physiological Society
publisher.none.fl_str_mv American Physiological Society
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844614358119743488
score 13.070432